文献
J-GLOBAL ID:202002216513510071
整理番号:20A0484136
健康な被験者における新規ハイブリッドFc-融合インターロイキン-1受容体アンタゴニスト,HL2351の安全性,耐容性および薬力学:最初のヒト研究【JST・京大機械翻訳】
Safety, tolerability and pharmacokinetics and pharmacodynamics of HL2351, a novel hybrid fc-fused interleukin-1 receptor antagonist, in healthy subjects: A first-in-human study
著者 (11件):
Oh Jaeseong
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea)
,
Huh Ki Young
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea)
,
Cho Young-Gyu
(Y Biologics, Daejeon, Republic of Korea)
,
Cha Ji-Eun
(HANDOK Inc., Seoul, Republic of Korea)
,
Kim Se-Jin
(HANDOK Inc., Seoul, Republic of Korea)
,
Yoon Seo Hyun
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea)
,
Park Sung Sup
(Department of Laboratory Medicine, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea)
,
Yoon Hyunyee
(Protein Immunology Core Facility, Biomedical Research Institutes, Seoul National University Hospital, Seoul, Republic of Korea)
,
Lee Jieon
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea)
,
Lee Howard
(Department of Clinical Pharmacology and Therapeutics, Seoul National University College of Medicine and Hospital, Seoul, Republic of Korea)
,
Lee Howard
(Department of Transdisciplinary Studies, Graduate School of Convergence Science and Technology, Seoul National University, Seoul, Republic of Korea)
資料名:
British Journal of Clinical Pharmacology
(British Journal of Clinical Pharmacology)
巻:
86
号:
2
ページ:
372-379
発行年:
2020年
JST資料番号:
C0957B
ISSN:
0306-5251
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)